The American Society of Hematology’s Treating Fairly Research Award provides dedicated funding to address health disparities and inequities in hematologic cancers and blood disordersoncodaily.comoncodaily.com. This award supports early- to mid-career investigators in the U.S., Canada, or Mexico who are pursuing research that will improve outcomes in underrepresented or underserved patient populations. Projects may focus on diseases like leukemia, lymphoma, myeloma, or other blood cancers with outcome gaps, and can range from basic science of health disparities to clinical or community interventions aimed at closing those gaps.
Eligibility Criteria:
- Open to ASH members who are MD, DO, or PhD investigators with faculty appointments in the U.S., Canada, or Mexico.
- Applicants should be within 15 years of their terminal degree/medical fellowship training (early-career and mid-career scientists).
- Must propose a research project that directly relates to health equity in hematology-oncology – e.g., investigating biological differences in minority populations, developing tailored therapies or outreach for disadvantaged groups, or evaluating interventions to reduce treatment access barriers.
- The Principal Investigator must devote substantial research effort (≥20% time) to the project. Only one submission per applicant is allowed.
- Note: Candidates for this award cannot simultaneously hold certain overlapping ASH awards (e.g., ASH-AMFDP) or the standard ASH Scholar Award in the same cycle.
Funding Details:
- Award amount: USD 200,000 total, which can be used over 1, 2, or 3 years at the investigator’s discretion.
- Funds may cover salary support (for the PI, trainees, or research staff), laboratory supplies, patient engagement costs, or other research expenses directly related to the project.
- No more than two awards will be granted to investigators at the same institution in this cycle, to maintain broad institutional diversity.
- Indirect costs: Not allowed – the full award must be applied to direct project costs.
- Awardees will have access to mentorship and networking through ASH’s health equity initiatives and are expected to share results (e.g., at the ASH annual meeting or via publications).
Deadline:
- Application deadline: December 17, 2025 (11:59 PM ET)oncodaily.com for the current award cycle
- Award notification: March 2026 (recipients will be notified prior to the ASH Annual Meeting).
- Award start date: Upon notification in spring 2026 – funding can be activated immediately to start the project, with the award term spanning up to three years from initiation.
Where to go for further information: